ASCO 2021: ICR research makes an impression at virtual cancer conference 08 Jun 2021 The ASCO Annual Meeting took place virtually over the weekend, with many ICR researchers attending and presenting abstracts. Here we look back over some of the highlights of this year’s meeting. Find out more Show/Hide
ASCO 2021: The science behind olaparib’s promise shown in the OlympiA early breast cancer trial 04 Jun 2021 The OlympiA trial results show the benefits of a targeted drug in patients with early-stage breast cancer and inherited BRCA mutations. We spoke to Chair of the OlympiA steering committee Professor Andrew Tutt about the landmark ICR research that underpins this major breakthrough. Find out more Show/Hide
ASCO 2021: Global cancer researchers reunite virtually 02 Jun 2021 We look ahead at some of the highlights that scientists from The Institute of Cancer Research will be presenting at this year’s virtual edition of the ASCO Annual Meeting. Find out more Show/Hide